Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response.
Poland
G A
GA
Mayo Vaccine Research Group, Clinical Pharmacology Unit, Mayo Clinic and Foundation, Rochester, MN 55905, USA. poland.gregory@mayo.edu
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D000914:Antibodies, Viral / Q000096:biosynthesis; D000956:Antigens, Viral / Q000276:immunology; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D007125:Immunogenetics; D008285:Major Histocompatibility Complex; D008457:Measles / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology*; D008458:Measles Vaccine
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters; D000914:Antibodies, Viral; D000956:Antigens, Viral; D006680:HLA Antigens; D008458:Measles Vaccine; C073119:TAP1 protein, human; C071692:TAP2 protein, human